『2 Minutes with Joey - RVMD Stock News』のカバーアート

2 Minutes with Joey - RVMD Stock News

2 Minutes with Joey - RVMD Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Revolution Medicines (RVMD) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • RVMD Today - Aug 12: Fresh RAS Drug Demand

    RVMD Today - Aug 12: Fresh RAS Drug Demand
    2026/08/12
    Hey there! It’s Joey, your friendly neighborhood investor, breaking down today’s market action. Today, we’re talking about Revolution Medicines, or RVMD for short. It was a pretty chill day, up just a smidge—like 0.84%.

    So, what went down? RVMD barely moved, but there’s some buzz around it. The stock's been getting attention for its new RAS cancer drugs, which are apparently in high demand. People are definitely noticing that, and it seems like the company is sitting pretty with a market cap of around $44 billion. Not too shabby, right?

    Now, why’s everyone talking about RVMD? Well, a couple of reasons. First off, the fresh demand for those RAS drugs is sparking interest from big pharma. You know how it goes—if something's hot, everyone wants a piece of it. Plus, there’s chatter that RVMD could be a takeover target, which is always a juicy topic in the investment world. It’s like that classic game of musical chairs; everyone’s trying to figure out who’s gonna grab it next. And on top of that, Handelsbanken Fonder just upped their stake in RVMD. So, clearly, some folks think this is a solid play.

    Oh, and here’s a little nugget to keep in mind: BeOne Medicines just teamed up with Revolution Medicines to work on some oncology therapies. Collaborations like this can mean more innovation and potential breakthroughs, so that’s definitely something to watch.

    So, to wrap it all up, RVMD had a quiet day but is definitely stirring up some excitement with that fresh RAS drug demand and big pharma interest. Remember, this info is just for fun and to keep you in the loop, not financial advice. Catch ya later!
    続きを読む 一部表示
    2 分
  • RVMD Today - Aug 11: Collaboration with BeOne Medicines

    RVMD Today - Aug 11: Collaboration with BeOne Medicines
    2026/08/11
    Hey there! It’s Joey here, your friendly longtime investor, breaking down the stock action for Revolution Medicines today. So, RVMD was in the red, down about 1.25%.

    What happened? Well, the stock had a bit of a rough day. It opened strong but lost some steam as the day went on. It got smoked a bit, but honestly, it wasn’t a huge surprise given the market vibes.

    Now, let’s talk about why this happened. There’s some buzz around a new collaboration with BeOne Medicines for oncology therapies. That sounds great on paper—like a solid partnership for tackling cancer. But sometimes, these deals can bring mixed feelings. Investors might be thinking about how this affects RVMD’s valuation. Some folks are excited, but others are a bit cautious, especially with Bank of America cutting their holdings in RVMD. Yeah, that one stung for sure. It’s like when your friend tells you they’re not feeling your favorite band anymore, and you’re left wondering if you should still rock out to their tunes.

    Also, TD Cowen reiterated a “Buy” rating on the stock, which is a positive sign. But with the mixed signals from the market, it’s like a rollercoaster of emotions for investors.

    One thing worth keeping in mind is that RVMD recently hit a new 12-month high. That’s a big deal! It shows that there’s been some serious interest in the stock lately.

    So, to wrap it up, RVMD had a bit of a tough day, but there are some exciting developments happening. Just remember, this is all for fun and info. I’m not here to tell you what to do with your money. Just keep an eye on the news and do what feels right for you. Catch you later!
    続きを読む 一部表示
    2 分
  • RVMD Today - Aug 10: Stays Steady Amid News

    RVMD Today - Aug 10: Stays Steady Amid News
    2026/08/10
    Hey there! It’s Joey here, your friendly investor buddy, and I’ve been in the game for a while. Today, we're chatting about Revolution Medicines, or RVMD for short. It was kind of a chill day, barely moved, just a tiny uptick of 0.16%.

    So, what went down? Well, RVMD had a pretty steady day. It didn’t get smoked, but it didn’t exactly shoot for the stars either. Just a slow and steady vibe. The trading volume was right around the average, so nothing too wild happening there.

    Now, why did it play out this way? Some interesting stuff came to light. TD Cowen kept the stock rating at a solid Buy, which is a thumbs-up for RVMD. That probably gave some investors a little boost of confidence. Also, BeOne snagged exclusive rights to four cancer medicines in certain Asian markets. That’s a big deal, right? More markets mean more potential sales. Plus, there’s been a growing demand for Daraxonrasib, one of their treatments. People are talking about it, and it sounds like that’s been helping RVMD bounce back a bit after some rough patches.

    Oh, and get this: Assenagon Asset Management picked up over 200,000 shares of RVMD. Major institutional buying can be a good sign, showing that some big players are betting on the stock.

    Now, looking ahead, Revolution Medicines is still in the game with Daraxonrasib and its pipeline. So, there’s definitely stuff cooking.

    Alright, that’s a wrap for today! Just remember, this is all for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません